Physician
Khan, Noorun
Khan, Noorun was paid $3.15M by Medicaid between Apr 2018 and Dec 2024, across 57 billing codes. Its largest line is 87633, Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets — 26% of everything it billed.
33Billing provider infoKHAN, NOORUN
PALOS HEIGHTS, IL 60463
PALOS HEIGHTS, IL 60463
33aNPI1548234073assigned 02/13/2006
33bProvider typeFamily Medicine Physician
28Total paid$3.15M
24GClaims59,642
24DCodes billed57
24AFirst – last monthApr 2018 – Dec 2024
Compared with peers
Next to other Family Medicine Physician providers in Illinois
Rank by total paid#26 of 2,947
Median peer was paid$43K
This provider vs. median74×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 275 | $3K | |
| 2019 | 503 | $4K | |
| 2020 | 1,033 | $21K | |
| 2021 | 753 | $15K | |
| 2022 | 883 | $30K | |
| 2023 | 10,536 | $584K | |
| 2024incomplete | 45,659 | $2.49M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 26% | 2,359 | 1,913 | $803K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 12% | 4,632 | 3,144 | $386K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 12% | 4,526 | 3,350 | $382K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 6.4% | 3,794 | 2,699 | $200K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 5.6% | 3,551 | 2,790 | $177K |
| 87486 | 3.7% | 2,937 | 2,301 | $117K | |
| 87581 | 3.7% | 2,921 | 2,300 | $116K | |
| 91320 | 3.2% | 692 | 338 | $102K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 3.1% | 2,166 | 1,649 | $96K |
| 87631 | 3.0% | 939 | 687 | $95K | |
| 99000 | 2.8% | 4,000 | 2,674 | $89K | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 2.7% | 2,211 | 1,447 | $85K |
45 more codes
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.9% | 2,114 | $60K |
| 87632 | 1.7% | 314 | $55K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.7% | 3,563 | $54K |
| 99308 | Subsequent nursing facility care, per day, straightforward | 1.6% | 1,799 | $50K |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | 1.3% | 1,678 | $40K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.0% | 2,822 | $33K |
| 91322 | <1% | 180 | $28K | |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 106 | $26K |
| 87634 | <1% | 448 | $22K | |
| 90677 | <1% | 78 | $21K | |
| 81025 | <1% | 2,682 | $14K | |
| 90653 | <1% | 182 | $10K | |
| 99305 | <1% | 119 | $10K | |
| 90658 | <1% | 491 | $9K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 232 | $8K |
| 81003 | <1% | 3,209 | $7K | |
| 99306 | Prolong nursin fac eval 15m | <1% | 154 | $6K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 117 | $6K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 245 | $5K |
| 96373 | <1% | 352 | $4K | |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 78 | $4K |
| 99384 | <1% | 37 | $4K | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 73 | $4K |
| 99307 | <1% | 189 | $2K | |
| 90732 | <1% | 18 | $2K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 984 | $2K |
| 99205 | Prolong outpt/office vis | <1% | 17 | $2K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 948 | $2K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 167 | $1K |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | <1% | 163 | $966.91 |
| 90686 | <1% | 43 | $837.03 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 633 | $715.56 |
| 90661 | <1% | 20 | $643.72 | |
| 93000 | <1% | 48 | $626.85 | |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 12 | $622.84 |
| 99326 | <1% | 14 | $452.67 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 205 | $329.96 |
| 90656 | <1% | 12 | $249.39 | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 12 | $237.20 |
| G0008 | Administration of influenza virus vaccine | <1% | 32 | $172.52 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 58 | $130.70 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 19 | $90.81 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 69 | $28.87 |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 128 | $24.41 |
| A9150 | Non-prescription drugs | 0% | 50 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.